Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Shares Outstanding (Weighted Average) (2024 - 2025)

RenovoRx's Shares Outstanding (Weighted Average) history spans 2 years, with the latest figure at $34.9 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 39.9% year-over-year to $34.9 million; the TTM value through Sep 2025 reached $34.9 million, up 39.9%, while the annual FY2024 figure was $22.3 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $34.9 million at RenovoRx, down from $36.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $36.6 million in Q2 2025 and bottomed at $14.9 million in Q1 2024.